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Cytotoxic antibodies or lymphocytes sensitized to specific cell surface antigens 
have been used to select somatic cell hybrids with specific chromosome exclu- 
sions. Spontaneous loss of chromosomes derived from one of the parental cells is 
a characteristic of somatic cell hybrids; thus in a population of hybrids, cells can 
pre-exist which have lost the chromosome coding for the cell surface antigen 
under selection and these cells escape the specific immunologic cytotoxic reac- 
tion and grow.  This phenomenon was first demonstrated with human-mouse 
somatic cell hybrids exposed to rabbit anti-human cell sera and complement (C) 
(1). Those  hybrid cells  which survived  the  cytotoxic lysis  were found to  be 
missing a human chromosome present in the original population. The chromo- 
some coding for this antigen(s) was assigned to human chromosome 11 both by 
linkage studies (1, 2) and by chromosome banding techniques. Antiserum to an 
antigen coded for by human chromosome 11  has also been raised in mice by 
immunization with  syngeneic human-mouse somatic cell  hybrids containing 
human chromosome  11  (3). Rabbit  anti-human  fl2-microglobulin serum  and 
complement (C)  have also been utilized to selectively eliminate, from popula- 
tions of human-mouse hybrid cells, those hybrids containing human chromo- 
some 15, the chromosome that codes for human ~2-microglobulin. ~  Allo-immune 
lymph node and spleen cells have been used to select interstrain murine somatic 
cell  hybrids.  This  cell-mediated immunoselection resulted  in  the  growth  of 
hybrid cells lacking the major histocompatibility complex (H-2) antigens of the 
parental strain,  against which the cytotoxic cells were sensitized, and concur- 
rently the number of mouse chromosome 17, known to code for these antigens, 
was reduced (4). 
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Some chromosomes are mandatorily retained in somatic cell hybrids because 
the  products  of genes  contained  on  these  chromosomes  are  essential  for the 
growth of the hybrid cells. The chromosome bearing the normal gene is retained 
in  hybrid  cells  when  nutritional  auxotrophic  mutants  (5)  or  drug-resistant 
mutant  cells  (e.g.,  thymidine  kinase  deficient or hypoxanthine-guanine-phos- 
phoribosyl-transferase deficient) (6) are hybridized with normal cells and grown 
in selective medium.  Obligate retention of the human  chromosome 7 has also 
been described (7) when normal mouse peritoneal macrophages are hybridized 
with a  simian virus 40 (SV40)2-transformed  human cell line.  The nondividing 
macrophage  is transformed  by the  presence  of the  SV40 genes integrated  on 
human  chromosome  7 and  such phenotypes of SV40-transformed  cells  as the 
expression of SV40 tumor (T) antigen (8), growth in agar (7), and tumorigenicity 
in nude mice (9), are expressed in these hybrid cells. No loss of human chromo- 
some 7 has been found in these hybrid cells, for presumably cells that lose this 
chromosome and the integrated virus are unable to proliferate. 
We have described (10) the preparation and reactivity of antisera prepared in 
mice to hybrids between syngeneic normal mouse peritoneal macrophages and 
SV40-transformed human cells. The immunizing hybrids contained, in addition 
to  the  complete  murine  genome,  the  human  chromosome  7  from  an  SV40- 
transformed human skin fibroblast (LN-SV) (7) as the only human chromosome. 
These antisera reacted in radioimmunoassays with human fibroblastic cell lines 
of many origins and with those human-mouse hybrid cells that contain human 
chromosome 7. No evidence could be found for any reactivity to SV40-controlled 
tumor-associated  specific  antigens  (SV40  TASA).  This  report  describes  the 
reactivity of these antisera in C-dependent lysis (CDL) and their use to immuno- 
select  clones  of hybrid  cells  containing  rearranged  human  chromosomes  7. 
Characterization  of these  clones  has  permitted  the  tentative  assignment  of 
several genes to different regions of human chromosome 7. 
Materials  and Methods 
Antisera.  Antiserum to hybrid cell line 53-87-1(1) clone 21 (cl 21),  a  C57BL  ×  LN-SV hybrid 
containing chromosome 7 as the only human chromosome, was prepared by weekly intraperitoneal 
injections of 2 ×  l0  T  cells into C57BL/6J male mice. Two separate pools of antisera were prepared, 
one from a  group of mice bled 10 days after eight immunizations and one from another group of 
mice bled 10 days after the seventh immunization. Antiserum to SV40 T  antigen was obtained 
from tumor-bearing hamsters injected with SV40 as newborns and used at 1:30 dilution. Fluores- 
cein  isothiocyanate-labeled rabbit immunoglobulin  (IgG) against hamster IgG was  purchased 
from  Cappel  Laboratories,  Inc.,  Downingtown,  Pa.  The rabbit serum  used  as  a  C  source  was 
obtained by repeated cardiac puncture. This C was selected after testing for spontaneous toxicity 
to human, mouse, and human-mouse hybrid cells. A pool of C57BL/6 antiserum to a human-mouse 
hybrid cell line of different chromosomal constitution was used as control. For absorption 1 ml of 
antiserum diluted 1:20 in Eagle's minimal essential medium (MEM) (Auto Pow; Flow Laborato- 
ries, Inc., Rockvill, Md.) supplemented with 10% fetal bovine serum (FBS) (Reheis Chemical Co., 
Chicago,  Ill.) was mixed with a  0.5 ml packed volume of cells (2  x  108 cells). The mixture was 
2 Abbreviations  used  in  this paper."  CDL,  complement-dependent lysis;  cl,  clone;  FBS,  fetal 
bovine serum; IS, immunoselected; LN-SV, SV40-transformed human skin fibroblast; PBS, phos- 
phate-buffered saline; RCF, relative centrifugal force; RI, reactivity index; RIA, radioimmunoas- 
say; SV40, simian virus 40; SV40 TASA,  SV40-controlled tumor-associated specific antigens; T, 
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incubated for 1 h  at 25°C with continuous shaking and for 15 h  at 4°C stationary. Antisera were 
separated by 1/2 h  centrifugation at 27,000 relative centrifugal force (RCF). 
Cells and Cell Cultures.  The cell lines and their origins are described in Tables I and II; the 
two hybrid clones 53-87-1(1) cl 21 and 53-87-3 cl 36 were kindly donated by Dr. C. M. Croce, Wistar 
Institute. All cell lines were grown in MEM and 10% FBS. Human peripheral blood lymphocytes 
were  separated  from  freshly  drawn  heparinized  blood  by  density  gradient  centrifugation  on 
Ficoll-Hypaque (sp gr 1,077).  Cells for cytetoxic assays or indirect radioimmunoassays were plated 
at confluent density 18 h  before testing. Single cell suspensions were prepared by washing cell 
monolayers  three  times  with  calcium-  and  magnesium-free  Dulbecco's  modified  phosphate- 
buffered saline (PBS) and then exposing them for 1 min to 0.25% trypsin and 0.1% EDTA in PBS. 
Cells were harvested in MEM containing 10% FBS and pipetted vigorously. 
Cloning was done by diluting cell suspensions in MEM and dispensing approximately I cell per 
well  into  a  fiat-bottom microtiter plate  (no.  3040;  Falcon Plastics,  Div.  of BioQuest,  Oxnard, 
Calif.). After cell attachment, wells containing one cell were scored and only cells from these wells 
were harvested when confluent. 
Cytotoxic Assay and Immunoselection Technique.  Appropriate dilutions of antisera (0.05 ml) 
were added to 0.05-ml aliquots of cell suspensions (4  ×  108 viable cells/ml) in wells of Linbro U- 
bottom microtiter test plates (IS-RB-96; Linbro Chemical Co.,  New  Haven,  Conn.). The sealed 
plates were shaken at 37°C  for 1/2 h  and then centrifuged at 225 RCF  for 3 rain,  the antisera 
aspirated, and 0.10 ml of freshly diluted (1:10),  ice-cold rabbit C added. MEM plus 10% FBS plus 10 
mM Hepes was used as diluent throughout. After another 30 min of shaking at 37°C, the plate was 
immersed in ice and 0.1 ml of ice-cold erythrosin-B (11) added. Viability counts of between 100-300 
cells were made in a hemocytometer. In addition to the antisera dilutions and C, each cell line was 
incubated  with  C  alone,  with  normal  mouse  serum  and  C,  and  with  the  lowest  dilution  of 
antiserum alone to assess these components for nonspecific cytotoxicity. The dilution of antisera 
necessary to give 50% CDL (CDL titer) was calculated from the graphed results. 
For immunoselections, the antisera were diluted 1:100 and the above procedure was followed 
except that the contents of the wells were removed aseptically after C incubation and a  sample 
taken for counts of viable cells. The cells were then either plated in T-25 Falcon flasks or cloned 
directly. 
Radioimmunoassay.  The  indirect  125I-radioimmunoassay  (RIA)  was  used  as previously de- 
scribed (10).  Triplicate determinations were  made for each serum or antiserum dilution and a 
reactivity  index  (RI)  was  calculated  for  each  cell  line  used.  This  index  was  determined  by 
subtracting the average number of counts per minute bound to cells in dilutions of normal serum 
from counts per minute bound to cells incubated with an equivalent dilution of cl 21 serum and 
then comparing the number of counts with those bound to the human cell line LN-SV. Calculation 
of the RI allowed for comparison between experiments: 
RI =  (cpm for cell x +  antiserum) -  (cpm for cell x +  normal serum)  ×  100. 
(cpm for LN-SV +  antiserum) -  (cpm for LN-SV +  normal serum) 
Chromosomes.  Chromosome banding of colcemid-arrested metaphase cells was performed by 
the trypsin-giemsa technique (12). 
fl~Glucuronidase.  ~-glucuronidase was assayed after starch gel electrophoresis of extracts of 
LN-SV cells, of a BALB/c mouse embryo fibroblast, of cl 36 cells, and of cells from immunoselected 
subclones of cl 36 using a  modification of the technique described by Chern and Croce (13). 
Tumorigenicity in "Nude" Mice.  Congenitally athymic nu/nu (nude) mice were produced in 
our colony by crossing (nu/nu) BALB/c males to C57BL/6J females and choosing nude offspring 
from  FI  intercrosses.  5-  to  6-wk-old  nude  mice  were  injected  subcutaneously  with  107  cells 
suspended in 0.1 ml MEM plus 10% FBS. The mice were checked periodically for the appearance of 
tumors. 7 wk postinjection, the mice were exsanguinated and the tumors were removed and fixed 
in formalin for histologic examination. Each cell line was injected into four nude mice. 
Results 
Reactivity of  Anti-c121 on Different Cell Lines.  The CDL of anti-cl 21 serum 
was assessed on a  variety of cell lines  (Table  I). The CDL titer on LN-SV and 
hybrid  cls  21  and  36,  derived  from LN-SV,  was  1:1,300  or  greater,  though  a KNOWLES,  SOLTER,  TRINCHIERI,  MALONEY,  FORD,  AND  ADEN  317 
TABLE  I 
Origin of Cell Lines,  CDL Titer, Reactivity Index, and Expression of SV40 T Antigen 
Reactivity  SV40 T 
Cells  Origin of cells  CDL titer*  index$ 
(RIA)  antigen 
Human 
LN-SV  SV40-transformed skin fibroblasts  >1:1,600  i00  + 
HT1080  Fibrosarcoma derived  1:500  102  - 
RDMc  Rhabdomyosarcoma derived  1:400  69  - 
1054-TR  SV40-transformed brain cens  <1:20  61  + 
W18Va2  SV40-transformed buccal mucosa cells  <1:20  71  + 
HeLe (D-98)  Cervical carcinoma derived  <1:20  45  - 
WI36  Embryonic lung fibroblasts  <1:200  41 
LN  Human  skin fibroblasts (not  parent of LN-  <1:20  40 
SV) 
Lymphocytes  Fresh peripheral blood lymphocytes  <1:200  2 
Monkey 
GMK  EVa cl 2A-1  SV40-transformed  African  green monkey kid-  <1:200  67  + 
ney cells 
African green monkey kidney cells  <1:200  46  CV-1 
Mouso-human hybrid 
53-87-1(1) el 21 
53-87-3 el 36 
53-87-3 cl 36 IS mass 
53-87-3 subclone 2, 3, 6, 8, 11 
53-67.3 subclone 1, 7, 9, 14 
53-87-3 cl 36 IS subclone 2 IS 
mass and subclones 
Rodent 
MKS-Bu-100 
C57-SV 
MC57G 
FS-1 
WIRL-SV 
LN-SV  × C57BL/6 mouse macrophage§  1:1,300  69  + 
LN-SV  x  BALB/c mouse macrophage§,ll  >1:1,600  69  + 
Same-I~l  1:400  65  + 
Cloned from cl 36 IS maser  1:400  49  + 
Clones from cl 36 IS mas~l  <1:200  20  + 
Derived from cl 36 IS subclone 2 IS~  I  <1:200  ND  + 
SV40-transformed  BALB/c  mouse  kidney  <1:200  7  + 
cells 
SV40-transformed  C57BL/6 mouse embryo fi-  <1:200  9  + 
broblasts 
Methy  Icholanth  rane-in  duced  tumor  in  <1:20  9  - 
C57BL/6 mouse 
SV40-induced hamster tumor  <1:200  7  + 
SV40-tranaformed rat liver  cells  <1:200  2  + 
* Antiserum dilution necessary to give 50% CDL. 
t  For calculation see Materials and Methods. 
§ Contains intact human chromosome  7. 
II See Table II for human chromosome  7 rearrangement. 
prozone was seen at dilutions lower than 1:40 (Fig.  1). Two other human cell 
lines,  HT1080,  derived from a fibrosarcoma,  and RDMc, derived from a rhab- 
domyosarcoma,  were  each susceptible  to specific  cytotoxic lysis by anti-cl  21 
serum.  Absorption  of  anti-cl  21  serum  with  HT1080  cells  removed  its  C- 
dependent cytotoxic activity to LN-SV.  The residual cytotoxicity is accounted 
for by the background cytotoxicity of C  (Fig.  1).  The remaining primate cells 
tested,  both transformed  (1054-TR,  Wl8Va2,  HeLa,  and GMK  EVa cl  2A-l) 
and  nontransformed  (LN,  WI38,  human  peripheral  blood lymphocytes,  and 
CV-1) were  not lysed with this antiserum  throughout the range of dilutions 
that gave maximal lysis on the LN-SV cell line.  No CDL of anti-cl 21 serum 
(above  the  C  toxicity  background)  was  found on any rodent  cell  line  tested 
(Fig.  1  and  Table  I).  These  cells  include  SV40-transformed  mouse  (MKS- 
Bul00,  C57SV)  and  rat  (WIRL-SV)  cells  and  cells  derived  from  an  SV40- 
induced hamster tumor (F5-1). 
Comparison of the reactivity of anti-cl 21 serum in indirect 125I-RIAs with its 
reactivity  in CDL revealed  some human cell lines that bound antiserum but 
were insusceptible  to CDL.  For example,  RDMc,  Wl8Va2,  and 1054-TR each 
bind equivalent amounts of serum yet only RDMc reacts with anti-cl 21 sera to 318  IMMUNOSELECTION  OF  HUMAN  CHROMOSOME  7 
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DILUTION  OF  ANTI-cl  21  SERUM 
Fro.  1.  Anti-c121  serum CDL tested on: (m---m), c121 mouse-human  hybrid  cells; (A---&), 
MC57G mouse cells; (e---e),  LN-SV human cells; and (©---O), LN-SV human cells after 
absorption with human cells. 
give  CDL  (Table  I).  The  susceptibility of each of the  human cells  lines  to 
general CDL was assayed using rabbit C and dilutions of another mouse anti- 
human-mouse hybrid cell sera of different reactivity; cells of all lines, except 
HeLa, were lysed. 
Immunoselection  of cl  36.  53-87-3 cl  36,  the  BALB/c  mouse  peritoneal 
macrophage ×  LN-SV hybrid, containing human chromosome 7 in one or two 
copies per metaphase plate as the only human chromosome (see Fig. 2)  was 
used for immunoselection. This hybrid cell line  was maximally lysed with 
anti-cl 21  serum and C  [CDL titer >1:1,600  (Table I)].  On immunoselection, 
99% of the cells were lysed. After transfer of the immunoselected population to 
a  T-25 culture flask, the surviving cells were allowed to grow to confluence. 
This immunoselected (IS)  population is designated cl 36 IS mass.  When the 
cells were tested with anti-cl 21  serum in CDL, a  decrease in reactivity was 
seen (CDL titer, 1:400; see Fig. 3). 
A series of subclones were derived from cl 36 IS mass (cl 36 IS subclones 1- 
14). C1 36 IS subclones 3, 6, 8, and 11, showed the same reduced reactivity as 
did the cl 36 IS mass population with anti-cl 21  serum in CDL (Fig. 3;  CDL 
titer, 1:400), while subclones 1, 7, 9, and 14, appeared essentially nonreactive 
(Fig. 3; CDL titer, <1:200).  cl 36 IS subclone 2, containing some cells reactive 
in CDL (23% lysis with antiserum 1:200), was again IS as before and four mass 
populations and a series of secondary subclones (cl 36 IS subclone 2 IS subclone 
1-8)  were derived from this immunoselection. These subclones were nonreac- 
tive in CDL with the antiserum (Fig. 3). 
The results from indirect RIAs (Table I) roughly parallel those obtained with 
cytotoxicity. The original hybrid cl 36  specifically bound 69%  of the counts 
bound by the  human parental  cell  line LN-SV;  cl  36  IS  mass gave  similar KNOWLES,  SOLTER,  TRINCHIERI,  MALONEY,  FORD,  AND  ADEN  319 
results  (RI, 65%). The average RI of the cl 36 IS subclones 2, 3,  6,  8,  and 11, 
each of which  contained  some cells reacting  in  CDL with  anti-cl  21  serum, 
dropped to 50%. The cl 36 IS subclones that showed no reactivity in C-mediated 
antiserum  cytotoxicity still  gave  an  RI of 20%  compared with  a  7% RI to a 
mouse cell line tested in parallel  (Table I). 
Chromosome Studies.  Although most of the original cl 36 hybrid cell lines 
contained an apparently normal human chromosome 7 (Fig. 4 A; Table II) 15% 
of these  cells  also  contained  a  chromosome  that,  from  the  trypsin-giemsa- 
banding  pattern,  appeared  to  represent  a  Robertsonian  translocation  with 
both centromeres  and  the  long  (q)  arms  of the human  chromosome  7 being 
retained  (7qter --* 7cen::7cen -* 7qter,  hereafter referred to as isoq7; see Fig. 
4 C), One karyotyped metaphase showed, in addition to the normal 7 and the 
isoq7, a  different centric fusion involving mouse chromosome 12 translocated 
to the pl region of the short (p) arm of the human chromosome 7 rea (HSA plus 
MMU) (Tqter --* 7 cen --, 7pl::12cen --* 12qter) (Fig. 4 D). 35% of the metaphases 
of cl 36 IS mass contained a  normal human chromosome 7.  47% of the meta- 
phases also contained  a  chromosome with banding patterns  (Fig.  4 B) corre- 
sponding to human chromosome 7, but the ratio of the short arm:total chromo- 
some length of this chromosome fell below 0.31, the lowest ratio found when 
measuring these parameters on the human chromosome 7 in the original cl 36 
7del  (7qter  --~  7pl)  (Fig.  4  B).  The  percentage  of cells  containing  the  isoq7 
remained the same as in the original  clone. 
A large number of metaphases from most of the subclones derived from cl 36 
IS were analyzed (Table II). Subclones 1 and 7 contained the human 7-mouse 
12 translocation  (Fig.  4 D) and  no normal  human  chromosome 7.  This  same 
translocation is found in 77% of the metaphases of subclone 14 and in addition, 
23%  of the cells contain a  single human 7 with the p terminal  deletion  (Fig. 
4 B).  Subclones 2  and  9  each  contained  a  significant  number  of metaphases 
with only the isoq7 chromosome (Figs. 2 B and 4 C), although some metaphases 
of subclone 9 (10%)  also had a  normal  human chromosome 7 and some meta- 
phases (36%) of subclone 2 contained the 7qter --~ 7pl chromosome. 
Analysis of over 200 metaphases of derivatives of cl 36 IS cl 2 IS (three mass 
populations and eight subclones) revealed no normal human chromosomes 7. 
The subclones contained  either the human  7-mouse  12 translocations  and/or 
the  human  isoq7;  the  majority  of the  mass  populations  contained  only the 
isoq7. 
SV40  T Antigen  and  Tumorigenicity.  Each  of the  clones  and  subclones 
were tested by indirect immunofluorescence with hamster antiserum specific 
for the SV40 nuclear T antigen and each expressed this antigen (Table I). Each 
of the cl 36 IS subclones and subclone 2 IS, subclones 3, 4, and 7 were injected 
into nude mice and all of these cell lines produced tumors (approximately 0.5 × 
1.0 cm) by 7 wk after injection which were classified histologically as undiffer- 
entiated sarcomas. 
B-Glucuronidase.  Visualization of fl-glucuronidase activity after starch gel 
electrophoresis indicated that the cl 36 IS subclones 1, 2, 7, 11, and 14, and cl 36 
IS subclone 2 IS cl 4 and 7 contained heteropolymers of the human and mouse 
isozymes. 320  IMMUNOSELECTION  OF  HUMAN  CHROMOSOME  7 
FIG.  2. A.  Karyotype of cl 36 before immunoselection. 
Discussion 
These results further define the human cell surface antigen(s) coded for by 
human  chromosome  7  (10). Antisera,  generated  in  mice  syngeneic to  the 
mouse-human hybrid cell containing chromosome 7 from the LN-SV parent 
cell as the only human chromosome, maximally reacted in CDL with LN-SV 
and  the  hybrid  clones  21  and  36  containing chromosome  7  from  LN-SV. 
Positive  cytotoxic reactions  were  observed  on  only two  of the  nine  other 
primate cell lines tested.  These results are in contrast with those obtained 
with  indirect  RIAs  on  the  same  cell  lines  in  which  there  was  significant 
binding to cells negative in CDL. It is possible that two or more cell surface 
antigens are coded for by genes located on human chromosome 7 derived from 
LN-SV and that only one of these antigens results in cytotoxic lysis of cells in 
the presence of antiserum and C. Thus, cells expressing this antigen are lysed; 
cells that do not express it are not susceptible to CDL but still bind antiserum 
due to the presence of the second antigen. Another possible explanation is that 
alleles at the same genetic locus segregate in the human population. LN-SV, 
HT1080,  and RDMc would thus contain the same allele and the other primate 
cells tested would possess different alleles. The latter alleles could then code KNOWLES,  SOLTER,  TRINCHIERI,  MALONEY,  FORD,  AND  ADEN  321 
FIG.  2.  B.  Karyotype of cl 36 IS subclone 2. 
for cell surface antigens capable of binding antiserum but incapable of antise- 
rum and C binding in a manner necessary for cytotoxic lysis. 
In confirmation of our previous data in RIA (10), anti-cl 21 serum appears to 
contain  no  reactivity  (CDL)  to  SV40  TASA  as  evidenced by  the  negative 
results on SV40-transformed primate (Wl8Va2, 1054-TR, and GMK EVa cl 2A- 
1)  and  SV40-transformed rodent  (F5-1,  WIRL-SV,  MKSBu-100,  C57SV)  cell 
lines. This despite the fact that cl 21 hybrid cells do express SV40  TASA as 
they act as effective immunizing cells (in C57BL/6 mice) generating cytotoxic 
T  cells specific for SV40-transformed syngeneic cells (14). It appears that in 
C56BL/6J the response to the SV40 TASA is primarily a T-cell response. 
Reaction of one clone of hybrid cells containing human chromosome 7 as the 
only human chromosome with anti-cl 21 serum and C resulted in greater than 
99% cell death. Those cells escaping CDL were grown to confluence either as a 
mass population or as clonal isolates. When the mass population of cl 36 IS was 
karyotyped, it was found that a  proportion of these cells still contained an 
intact chromosome 7 (Table II). Approximately half of the cl 36 IS cells were 
susceptible to C-dependent antiserum lysis (Fig. 3).  Clones initially derived 
from this mixed population fall into two groups: those lacking the relevant 322  IMMUNOSELECTION  OF  HUMAN  CHROMOSOME  7 
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DILUTtON  OF  ANTI-¢I  21  SERUM 
Fro.  3.  Anti-el 21  serum CDL tested on hybrid el 36 cells before and after immunoselec- 
tion:  (Q-Q),  cl 36;  (m-I),  cl 36 IS mass;  (D---D),  cl 36 IS subclone 2;  (G-@),  cl 36 IS 
subclones 3, 6, 8, and 11 (mean and range); (A -  &), eight subclones ofc136 IS subclone 2 and 
cl 36 IS subclones 1,  7, 9, and 14 (mean and range). 
portion of the short arm of 7,  nonreactive with antiserum and C;  and cells 
containing this chromosome in a  proportion of their metaphases and propor- 
tionately reactive with antiserum and C. Variable expression of the antigen 
throughout the cell cycle and inaccessibility of the cells tb either antiserum or 
C because of position in cell aggregates are but two explanations for escape 
from specific lysis. Those cells containing rearranged chromosomes missing a 
portion of the short arm and those missing the entire short arm are no longer 
reactive with the antisera in CDL and bind only 20% as many counts as the 
parent human cell LN-SV in RIA. Absorption of anti-cl 21  serum with cells 
containing isoq7 did not reduce counts bound to LN-SV in RIA. The data from 
immunoselection experiments indicate that the antigen(s) responsible for CDL 
is coded for by a gene(s) located on the p arm of  the human chromosome 7. This 
remaining reactivity in  RIA  might represent  an  additional minor  antigen 
coded for by the long arm of the human chromosome 7 and this possibility is 
being  tested  by  direct  immunization with  hybrids  containing isoq7.  It  is 
possible that cryptic rearrangements of the short arm of human chromosome 7 
into the mouse chromosomal material may have occurred in some or all of 
these hybrid clones. If translocations of this sort have occurred then a position 
effect for the normal expression of  this antigen would have to be postulated. 
Clones of cells missing the distal portion of the p arm of chromosome 7 and 
cells missing the entire p  arm of human chromosome 7 retained the trans- 
formed phenotype associated with the integrated SV40  genome. SV40  T anti- 
gen was expressed in all cells of the IS hybrids and all of the clones caused 
tumors in nude mice. These data indicate that the SV40 genome is integrated 
in this hybrid clone either on the q  arm of human chromosome 7 or in the KNOWLES~  SOLTER,  TRINCHIERIy  MALONEY,  FORD,  AND  ADEN  323 
Fro.  4.  (A) Human chromosomes 7 from three different metaphases of cl 36; (B) Human 
chromosome  7qKpl from three  different metaphases of cl 36  IS subclones;  (C) Human 
chromosome isoq7 from three different metaphases ofcl 36 IS subclones; (D) Human-mouse 
chromosome 7 translocation (human 7qk7plT-Tkl2  mouse) (see text) from three different 
metaphases of cl 36 IS subclones. 
centromere  region  and  further  validate  the  findings  of Croce  et  al.  (7,  9)  of 
mandatory  retention  of human  chromosome  7  in  hybrid  cells  prepared  by 
fusing  normal  mouse  macrophages  with  the  SV40-transformed  human  cell 
line, LN-SV. The long arm of the human chromosome 7 was present in each of 324  IMMUNOSELECTION  OF  HUMAN  CHROMOSOME  7 
TABLE  II 
Chromosome Constitution of Clone 36 and Immunoselected (IS) Derivatives of Clone 36 
Rea  Chromosome 
Normal  Humans  Human  Metaphases 
(HSA + MMU)  number mode 
human 7*  7qter ~  7pl  isoq7§  (7::12~1  analyzed n  (ranges) 
cl 36 
cl 36 IS mass 
cl 36 IS 
Subclone  1 
Subclone  3 
Subclone  7 
Subclone  9 
Subclone 11 
Subclone  14 
Subclone 2 
Subclone 2 IS 
Mass A 
Mass B 
Mass C 
Mass E 
Subclone  2 
Subclone  3 
Subclone  4 
Subclone  5 
Subclone  7 
Subclone  8 
Subclone  11 
Subclone  12 
%  %  %  % 
95  15  5  20  42 (38-44) 
35  47  14  4  26  42 (40-43) 
100  40  40 (38-41) 
12  33  9  56  23  40 (37-42) 
100  64  40 (38-41) 
10  100  10  40 (38-41) 
88  12  75  14  41 (40-43) 
23  77  43  40 (37-43) 
36  64  ll  40 (39-41) 
2  98  42  40 (!39-43) 
100  38  41  (38-43) 
100  20  41  (38-42) 
100  17  78 (74-81) 
68  32  32  41 (38-43) 
100  11  40 (38-79) 
100  5  41  (40-41) 
100  17  41  (39-42) 
100  II  40 (39-41) 
100  3  40 
100  8  40 (40-43) 
* Arm ratio:  short arm/total chromosome length  (0.31-0.43),  see Fig. 4 A. 
§  See Fig. 4 C 
S Arm ratio:  short arm/total chromosome length (0.21-0.31),  see Fig. 4 B. 
II  See Fig. 4 D. 
over 400 metaphase spreads from 17 subclones and 4 mass populations of cl 36 
subjected to immunoselective pressures against  chromosome 7.  The portion of 
chromosome 7 containing the SV40 genome is retained in the hybrid cells and 
presumedly  the  conservation  of  SV40  is  required  for  growth  of the  mouse 
macrophage which as a normal cell does not divide. Barring translocation of the 
relevant portion of the long arm of the chromosome 7 for the SV40 genome to a 
mouse chromosome, the centromere of chromosome 7 must also be retained to 
ensure the segregation of the integrated SV40. Since immunoselection results in 
growth of only those cells containing rearranged chromosomes already present 
at the time of the selection event we can only hypothesize about the conditions 
leading to the presence of the three chromosome rearrangements in the original 
hybrid  population  before  immunoselection.  Assuming  that  breakage  events 
along the entire chromosome 7 are equally probable and that retention of the 
SV40  integration  site  is  obligatory,  we  should  find  some  clones  missing  the 
intact long arm of chromosome 7. Long arm rearrangements should be found but 
in fact we only observed various short arm losses. This could indicate that either 
the short arm is more susceptible to breakage, or that long arm rearrangements 
did occur but were missed in the limited number of cells surveyed or that the 
centromere  through  q  terminus  of the  human  chromosome  7  is  necessarily 
retained due to coadaptation of the SV40 integration site and some other gene(s) 
contained on chromosome 7. This point should be resolved by further investiga- 
tion of hybrid clones of different origin. KNOWLES,  SOLTER,  TRINCHIERI,  MALONEY,  FORD,  AND  ADEN  325 
Analysis  for  f~-glucuronidase of clones  containing  each  of the  rearranged 
human chromosomes 7 indicated that both mouse and human enzyme forms and 
heteropolymers between them were expressed in these hybrids. This result is in 
agreement with the previous assignment of  the human enzyme to chromosome 7 
(13) and provides preliminary evidence that this gene might be located on the 
long arm of chromosome 7. 
These experiments suggest that rearrangements of any chromosome retained 
by stringent selection in somatic cell hybrids may be obtained in hybrid cells 
providing cell surface antigens coded for by the same chromosome exists. 
Summary 
Immunoselection via complement-dependent lysis of human-mouse somatic 
cell hybrids containing  chromosome 7,  with  antisera  reactive to  cell  surface 
antigen(s)  coded for by chromosome 7,  has resulted in growth of somatic cell 
hybrids containing rearranged human chromosome 7s.  Investigation of these 
hybrids has localized the gene(s) coding for the relevant cell surface antigen(s) 
to the short arm of human chromosome 7. The simian virus 40 integration site 
and the gene coding for human  B-glucuronidase appear to be localized to the 
long arm of chromosome 7 in this hybrid clone. 
Received for publication 25 May 1976. 
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